Scotiabank Initiates Coverage On CGI with Sector Outperform Rating, Announces Price Target of C$130
Scotiabank analyst Divya Goyal initiates coverage on CGI (TSX:GIB) with a Sector Outperform rating and announces Price Target of C$130.
MKM Partners Initiates Coverage On Palo Alto Networks with Buy Rating, Announces Price Target of $250
MKM Partners analyst Catharine Trebnick initiates coverage on Palo Alto Networks (NASDAQ:PANW) with a Buy rating and announces Price Target of $250.
Needham Initiates Coverage On Snowflake with Buy Rating, Announces Price Target of $240
Needham analyst Mike Cikos initiates coverage on Snowflake (NYSE:SNOW) with a Buy rating and announces Price Target of $240.
Keybanc Initiates Coverage On Alight with Overweight Rating, Announces Price Target of $15
Keybanc analyst Scott Schoenhaus initiates coverage on Alight (NYSE:ALIT) with a Overweight rating and announces Price Target of $15.
Keybanc Initiates Coverage On Doximity with Sector Weight Rating
Keybanc initiates coverage on Doximity (NYSE:DOCS) with a Sector Weight rating.
Keybanc Initiates Coverage On GoodRx Holdings with Sector Weight Rating
Keybanc analyst Scott Schoenhaus initiates coverage on GoodRx Holdings (NASDAQ:GDRX) with a Sector Weight rating.
Keybanc Initiates Coverage On Health Catalyst with Sector Weight Rating
Keybanc analyst Scott Schoenhaus initiates coverage on Health Catalyst (NASDAQ:HCAT) with a Sector Weight rating.
Keybanc Initiates Coverage On Omnicell with Overweight Rating, Announces Price Target of $130
Keybanc analyst Scott Schoenhaus initiates coverage on Omnicell (NASDAQ:OMCL) with a Overweight rating and announces Price Target of $130.
Keybanc Initiates Coverage On Recursion Pharmaceuticals with Overweight Rating, Announces Price Target of $20
Keybanc analyst Scott Schoenhaus initiates coverage on Recursion Pharmaceuticals (NASDAQ:RXRX) with a Overweight rating and announces Price Target of $20.
Keybanc Initiates Coverage On R1 RCM with Overweight Rating, Announces Price Target of $30
Keybanc analyst Scott Schoenhaus initiates coverage on R1 RCM (NASDAQ:RCM) with a Overweight rating and announces Price Target of $30.